These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 485132)

  • 41. Concentrations of gentamicin and amikacin in human kidneys.
    Edwards CQ; Smith CR; Baughman KL; Rogers JF; Lietman PS
    Antimicrob Agents Chemother; 1976 Jun; 9(6):925-7. PubMed ID: 938022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of ampicillin-amikacin and ampicillin-rifampin on enterococci.
    Iannini PB; Ehret J; Eickhoff TC
    Antimicrob Agents Chemother; 1976 Mar; 9(3):448-51. PubMed ID: 1045914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavior of amikacin in renal parenchyma of normal rats and of rats with acute obstructive renal insufficiency.
    Rudhardt M; Fabre J
    Nephron; 1979; 24(6):287-91. PubMed ID: 514429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. UK-18892, a new aminoglycoside: an in vitro study.
    Wise R; Andrews JM
    Antimicrob Agents Chemother; 1978 Aug; 14(2):228-33. PubMed ID: 100050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Change in serum pH in the bioassay of aminoglycoside antibiotics.
    Wolff M; Chmel H; Eng RH
    J Infect Dis; 1982 Apr; 145(4):585. PubMed ID: 7069238
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
    Lode H; Grunert K; Kemmerich B; Koeppe P
    Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
    Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F
    J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amikacin therapy of severe infections produced by gram-negative bacilli resistant to gentamicin.
    Valdivieso M; Bodey GP
    Am J Med Sci; 1977; 273(2):177-84. PubMed ID: 860733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
    Strausbaugh LJ; Mandaleris CD; Sande MA
    J Lab Clin Med; 1977 Apr; 89(4):692-701. PubMed ID: 321713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetical, histological, and histochemical investigation on the ototoxicity of gentamicin, tobramycin, and amikacin (author's transl)].
    Federspil P; Schätzle W; Tiesler E
    Arch Otorhinolaryngol; 1977 Jul; 217(2):147-66. PubMed ID: 578730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
    Ling GV; Conzelman GM; Franti CE; Ruby AL
    Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro evaluations of amikacin: an assessment of the currently used methods of disk diffusion and dilution susceptibility, antimicrobial synergy, and the measurement of amikacin concentrations.
    Jones RN
    Am J Med; 1986 Jun; 80(6B):88-97. PubMed ID: 3524220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical pharmacokinetics of amikacin in dogs.
    Baggot JD; Ling GV; Chatfield RC
    Am J Vet Res; 1985 Aug; 46(8):1793-6. PubMed ID: 4037511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experimental study of the antibacterial activity and chemotherapeutic effectiveness of amikacin sulfate].
    Lobuseva AN; Kuznetsova SM; Samoĭlova LN
    Antibiot Med Biotekhnol; 1985 Oct; 30(10):776-80. PubMed ID: 4091515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantification of amikacin and kanamycin in serum using a simple and validated LC-MS/MS method.
    Dijkstra JA; Sturkenboom MG; Hateren Kv; Koster RA; Greijdanus B; Alffenaar JW
    Bioanalysis; 2014 Aug; 6(16):2125-33. PubMed ID: 25331857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of antibiotic resistance with Vmax/Km ratio of enzymatic modification of aminoglycosides by kanamycin acetyltransferase.
    Radika K; Northrop DB
    Antimicrob Agents Chemother; 1984 Apr; 25(4):479-82. PubMed ID: 6375556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amikacin: a rapid and sensitive radioimmunoassay.
    Lewis JE; Nelson JC; Elder HA
    Antimicrob Agents Chemother; 1975 Jan; 7(1):42-5. PubMed ID: 1169906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diffusion of amikacin in the lungs].
    Saux MC; Crockett R; Fourtillan JB; Leng B; Couraud L
    Pathol Biol (Paris); 1986 Feb; 34(2):113-7. PubMed ID: 3517776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of the pharmacokinetics of amikacin and gentamicin.
    Wise R; Walker JM; Mitchard M
    J Antimicrob Chemother; 1981 Jul; 8 Suppl A():45-9. PubMed ID: 7263565
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetics of amikacin in pony foals after a single intramuscular injection.
    Brown MP; Gronwall RR; Martinez DS; Beal C
    Am J Vet Res; 1986 Feb; 47(2):453-4. PubMed ID: 3954234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.